BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12384401)

  • 1. The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis.
    Cragg MS; Chan HT; Fox MD; Tutt A; Smith A; Oscier DG; Hamblin TJ; Glennie MJ
    Blood; 2002 Nov; 100(9):3068-76. PubMed ID: 12384401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia.
    Alfarano A; Indraccolo S; Circosta P; Minuzzo S; Vallario A; Zamarchi R; Fregonese A; Calderazzo F; Faldella A; Aragno M; Camaschella C; Amadori A; Caligaris-Cappio F
    Blood; 1999 Apr; 93(7):2327-35. PubMed ID: 10090943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower levels of surface B-cell-receptor expression in chronic lymphocytic leukemia are associated with glycosylation and folding defects of the mu and CD79a chains.
    Vuillier F; Dumas G; Magnac C; Prevost MC; Lalanne AI; Oppezzo P; Melanitou E; Dighiero G; Payelle-Brogard B
    Blood; 2005 Apr; 105(7):2933-40. PubMed ID: 15591116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-apoptotic TP53 homolog TAp63 is repressed via epigenetic silencing and B-cell receptor signalling in chronic lymphocytic leukaemia.
    Humphries LA; Godbersen JC; Danilova OV; Kaur P; Christensen BC; Danilov AV
    Br J Haematol; 2013 Dec; 163(5):590-602. PubMed ID: 24117128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous intracellular expression of B-cell receptor components in B-cell chronic lymphocytic leukaemia (B-CLL) cells and effects of CD79b gene transfer on surface immunoglobulin levels in a B-CLL-derived cell line.
    Minuzzo S; Indraccolo S; Tosello V; Piovan E; Cabrelle A; Trentin L; Semenzato G; Amadori A
    Br J Haematol; 2005 Sep; 130(6):878-89. PubMed ID: 16156858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
    Myklebust JH; Brody J; Kohrt HE; Kolstad A; Czerwinski DK; Wälchli S; Green MR; Trøen G; Liestøl K; Beiske K; Houot R; Delabie J; Alizadeh AA; Irish JM; Levy R
    Blood; 2017 Feb; 129(6):759-770. PubMed ID: 28011673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias.
    Golay J; Luppi M; Songia S; Palvarini C; Lombardi L; Aiello A; Delia D; Lam K; Crawford DH; Biondi A; Barbui T; Rambaldi A; Introna M
    Blood; 1996 Mar; 87(5):1900-11. PubMed ID: 8634438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cyclins D-type in B-chronic lymphoproliferative disorders.
    Sola B; Roué G; Duquesne F; Avet-Loiseau H; Macro M; Salaün V; Troussard X
    Leukemia; 2000 Jul; 14(7):1318-9. PubMed ID: 10914560
    [No Abstract]   [Full Text] [Related]  

  • 9. Aberrations of the B-cell receptor B29 (CD79b) gene in chronic lymphocytic leukemia.
    Thompson AA; Talley JA; Do HN; Kagan HL; Kunkel L; Berenson J; Cooper MD; Saxon A; Wall R
    Blood; 1997 Aug; 90(4):1387-94. PubMed ID: 9269755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant B cell receptor signaling from B29 (Igbeta, CD79b) gene mutations of chronic lymphocytic leukemia B cells.
    Gordon MS; Kato RM; Lansigan F; Thompson AA; Wall R; Rawlings DJ
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5504-9. PubMed ID: 10792036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative splicing of CD79a (Ig alpha) and CD79b (Ig beta) transcripts in human B-CLL cells.
    Alfarano A; Circosta P; Vallario A; Camaschella C; Indraccolo S; Amadori A; Caligaris-Cappio F
    Curr Top Microbiol Immunol; 1999; 246():241-6; discussion 247-8. PubMed ID: 10396062
    [No Abstract]   [Full Text] [Related]  

  • 12. Defective assembly of the B-cell receptor chains accounts for its low expression in B-chronic lymphocytic leukaemia.
    Payelle-Brogard B; Magnac C; Alcover A; Roux P; Dighiero G
    Br J Haematol; 2002 Sep; 118(4):976-85. PubMed ID: 12199775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia.
    Chen L; Widhopf G; Huynh L; Rassenti L; Rai KR; Weiss A; Kipps TJ
    Blood; 2002 Dec; 100(13):4609-14. PubMed ID: 12393534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Widespread B29 (CD79b) gene defects and loss of expression in chronic lymphocytic leukemia.
    Thompson AA; Do HN; Saxon A; Wall R
    Leuk Lymphoma; 1999 Feb; 32(5-6):561-9. PubMed ID: 10048429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma.
    Blix ES; Irish JM; Husebekk A; Delabie J; Forfang L; Tierens AM; Myklebust JH; Kolstad A
    BMC Cancer; 2012 Oct; 12():478. PubMed ID: 23072591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G protein subunit G alpha 16 expression is restricted to progenitor B cells during human B-cell differentiation.
    Mapara MY; Bommert K; Bargou RC; Leng C; Beck C; Ludwig WD; Gierschik P; Dörken B
    Blood; 1995 Apr; 85(7):1836-42. PubMed ID: 7703490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4 rescues surface IgM expression in chronic lymphocytic leukemia.
    Guo B; Zhang L; Chiorazzi N; Rothstein TL
    Blood; 2016 Jul; 128(4):553-62. PubMed ID: 27226435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous signaling of CD79b and CD19 is required for the fitness of Burkitt lymphoma B cells.
    He X; Kläsener K; Iype JM; Becker M; Maity PC; Cavallari M; Nielsen PJ; Yang J; Reth M
    EMBO J; 2018 Jun; 37(11):. PubMed ID: 29669863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetrical phosphorylation and function of immunoreceptor tyrosine-based activation motif tyrosines in B cell antigen receptor signal transduction.
    Pao LI; Famiglietti SJ; Cambier JC
    J Immunol; 1998 Apr; 160(7):3305-14. PubMed ID: 9531288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion.
    Francia di Celle P; Mariani S; Riera L; Stacchini A; Reato G; Foa R
    Blood; 1996 May; 87(10):4382-9. PubMed ID: 8639799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.